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Introduction
HIV-infected individuals have increased susceptibility to lower 
respiratory tract infections (LRTIs)1,2, which account for 75–98% 
of lung complications in antiretroviral therapy (ART)-naïve HIV-
infected adults worldwide3,4. Predisposition to LRTIs is largely 
attributed to HIV-induced impairment of lung immunity, including 
reduced frequency of respiratory antigen-specific alveolar CD4+ 
T cells5–7 as well as impaired alveolar macrophage function5,8. HIV 
infection is also associated with CD8+ T cell alveolitis, a condition 
characterized by the influx of HIV-specific CD8+ T cells into the 
lung9,10. While these immune cell perturbations partly underlie 
propensity for LRTIs in HIV-infected individuals, the impact of 
HIV infection on the composition and functions of other immune 
cell populations in the lung is not well defined.
Several studies have reported alterations in the proportions and 
functions of different immune cell populations in peripheral blood 
in HIV-infected individuals11–14. While peripheral blood CD4+ 
T cell depletion and an increase in CD8+ T cells are hallmarks 
of progressive untreated chronic HIV infection15, depletion of 
B cells11 and aberrant NK cell function and redistribution from 
CD56dim towards CD56neg subsets has been observed during early 
and chronic HIV infection12. Two major human γδ T cells subsets 
(designated Vδ1 or Vδ2) are also altered in HIV-infected 
individuals, with an increase in the Vδ1 subset and a decrease 
in the Vδ2 subset13. Furthermore, increased proportions of non-
classical and intermediate monocytes and depleted myeloid 
and plasmacytoid dendritic cell subsets have been reported in 
individuals with high plasma HIV viral load14,16,17.
We, therefore, undertook a comprehensive characterisation of 
the impact of HIV infection on immune cell populations in the 
lung. We obtained paired bronchoalveolar lavage (BAL) fluid and 
peripheral blood from HIV-uninfected and asymptomatic HIV-
infected, antiretroviral therapy (ART)-naïve Malawian adults. We 
analysed and compared the proportions and numbers of CD4+ 
and CD8+ T cells, B cells, NK cell subsets, γδ T cells, mono-
cytes, dendritic cell subsets, neutrophils and alveolar macrophages 
in samples from HIV-infected and uninfected individuals.
Methods
Study participants
The study was conducted at the Queen Elizabeth Central Hospital, 
a large teaching hospital in Blantyre, Malawi. Participants were 
recruited from the hospital’s voluntary counselling and testing 
(VCT) and ART clinics. They were adults aged ≥18yrs 
comprising healthy HIV-1-uninfected and asymptomatic 
HIV-1-infected volunteers with no clinical evidence of active 
disease and willing to undergo bronchoscopy and BAL for 
research purposes18. Clinical diagnosis and radiographic exami-
nation were used to exclude individuals with active disease, 
including TB, from the study. No latent TB tests were carried out 
on the participants. The study participants were recruited from 
the same catchment area, with relatively similar environmental 
exposures. HIV testing was performed on whole blood using 
two commercial point-of-care rapid HIV test kits, Determine 
HIV 1/2 kit (Abbott Diagnostic Division) and Unigold HIV 
1/2 kit (Trinity Biotech Inc.). A participant was considered HIV-
uninfected if the test was negative by both kits or HIV-infected 
if the test was positive by both kits. If Determine and Unigold 
results were discordant, a third rapid test using Bioline 
HIV 1/2 kit (Standard Diagnostics Inc.) was performed to resolve 
the discordance. No baseline viral loads were done on the HIV-
infected individuals. However, none of the participants were on 
ART at the time of recruitment to the study, but all initiated ART 
after sample collection according to the ‘test and treat’ Malawi 
national treatment guidelines. Exclusion criteria for the study were: 
current or history of smoking, use of immunosuppressive drugs, 
severe anaemia (Hb<8g/dl) and known or suspected pregnancy. 
The research ethics committee of Malawi College of Medicine 
approved the study under approval number P.03/16/1907 and all 
participants provided written informed consent.
Sample collection and experimental procedures
Bronchoscopy and BAL were performed on all participants as 
previously described5,6,8. Briefly, we used Instillagel to lubricate 
the nostrils and 2% lignocaine for vocal cords and the airways. A 
fiber-optic bronchoscope (Olympus, UK) was passed to the level of 
a sub-segmental bronchus of the right middle lobe and four 50 ml 
aliquots of sterile normal saline at 37°C instilled and removed 
using gentle hand suction. A typical BAL return from a 200ml 
instill is 100–140ml. The aspirated bronchoalveolar lavage fluid 
was placed into 50ml falcon tubes and transferred immediately 
to the laboratory for processing within 30 min. The fluid was 
filtered using sterile gauze and centrifuged at 500g for 10min. 
The supernatant was removed, the cell pellet was resuspended 
and washed with PBS by spinning in a centrifuge at 500g for 
10min. The supernatant was removed and discarded while the 
cell pellet was resuspended in complete media. Upon microscopic 
examination, the cell pellet contained <5% bronchial epithelial 
cells or squamous cells. Due to time taken from BAL isolation 
and sample acquisition, there is a potential for changes in cell 
viability, especially neutrophils, however, the a standardised study 
protocol was applied to both study groups to minimise the time 
from isolation to acquisition. Peripheral blood was also obtained 
from study participants for full blood count (FBC) and peripheral 
blood mononuclear cell (PBMC) isolation using density gradient 
centrifugation. Cell counts in BAL cells and PBMCs isolated 
from each sample were performed using a haemocytometer.
Immunophenotyping
Whole BAL cells (1 × 106 cells) and PBMCs (1 × 106 cells) 
were stained with predetermined optimal concentration of fluoro-
chrome-conjugated monoclonal antibodies against human cell 
surface proteins. Two separate antibody panels targeting 
lymphocytic and myeloid cells were used. The lymphocyte 
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Figure 1. Representative flow cytometry plots for characterising lymphocytes in BAL fluid from HIV-uninfected adult. BAL cells were 
stained with fluorochrome-conjugated antibodies.
panel consisted of anti-CD3 PE/Cy5, anti-CD4 Bv421, 
anti-CD8 APC-Cy7, anti-CD19 PE, anti-CD56 APC, anti-TCR 
γδ FITC, and anti-CD45 PE-CF594. The myeloid panel consisted 
of anti-CD45 PE-CF594, anti CD14 Bv421, anti-CD16 PE/Cy7 
PC7, anti-HLADR PE/Cy5, anti-CD66 FITC, anti-CD206 APC, 
anti-CD11c APC/Cy7 and anti-CD123 Bv510. Further details of 
the antibodies are in Supplementary Table 1. All samples were 
analysed using a BD LSRFortessa flow cytometer (Becton 
Dickinson, USA).
Statistical analysis
Statistical analyses and graphical presentation were performed 
using GraphPad Prism 5 (GraphPad Software, USA). We used 
FlowJo v10 software (Treestar, USA) to analyse flow cytometry 
data. The numbers of cell subsets in BAL fluid were estimated 
by calculating the proportion of a particular subset relative to the 
total number (1 × 106 cells) of stained cells. The cell count was 
first calculated as number of cells relative to the BAL volume 
return of each individual, and this was then standardised to cells 
per 100ml BAL fluid as previously published5,6. In PBMCs, the 
absolute numbers were obtained by calculating the proportion 
of a particular subset relative to the full blood count (FBC) data, 
specifically, lymphocyte and monocytes counts. Data were ana-
lysed using Mann Whitney U test. Results are given as median 
and interquartile range (IQR). Differences were considered 
statistically significant when p<0.05.
Results
Study participants and samples
We recruited 20 HIV-uninfected healthy controls (median age 
[range] (32[18-52]; male:female, 12:8) and 17 asymptomatic 
HIV-infected adults (median age [range] (33 [24-58]; male:
female, 8:9). The CD4 count (median [range]) was lower in 
HIV-infected adults compared to the HIV-uninfected controls 
(365[218-541]) vs. 731[541-888] cells/ul, p=0.0024). The main 
characteristics of the participants are summarised in Table 1. 
Not all experimental assays were performed on all study 
participants.
CD8+ T cells, B cells and γδ T cells contribute to HIV-
associated lymphocyte infiltration in the alveolar space
We investigated the impact of HIV infection on the proportion 
and numbers of lymphocyte populations using flow cytometry. 
The gating strategy is illustrated in Figure 1. We found that the 
proportions and numbers of lymphocytes in BAL fluid were 
higher in HIV-infected adults compared to HIV-uninfected 
(median 20.8% vs. 8.5%, p=0.0004 and median 1 × 107 vs. 
2.7 × 106 cells/100ml of BAL fluid, p=0.0005, respectively) 
(Figure 2A and 2B). We next determined the cell subsets that 
were responsible for the increased frequency of lymphocytes in 
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Figure 2. Proportions and numbers of CD4+ T cells, CD8+ T cells and CD19+ B cells in BAL fluid from ART-naïve HIV-infected compared 
to HIV-uninfected individuals. BAL cells were stained with fluorochrome-conjugated antibodies. A) Proportion of lymphocytes in BAL fluid. 
B) Numbers of lymphocytes in BAL fluid. C) Proportion of CD4+ and CD8+ T cells in BAL fluid. D) Numbers of CD4+ and CD8+ T cells in 
BAL fluid. E) Proportion of B cells in BAL fluid. F) Numbers of CD19+ B cells in BAL fluid. The horizontal bars represent median and 95% 
confidence intervals. Data were analyzed using Mann Whitney U test. (HIV-, n=20; HIV+ ART-, n=17).
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Figure 3. Proportions and numbers of γδ T cells and NK cells in BAL fluid from ART-naïve HIV-infected compared to HIV-uninfected 
individuals. BAL cells were stained with fluorochrome-conjugated antibodies. A) Proportion of γδ T cell subsets in BAL fluid. B) Numbers of 
γδ T cell subsets in BAL fluid. C) Proportion of NK cell subsets in BAL fluid. D) Numbers of NK cell subsets in BAL fluid. The horizontal bars 
represent median and 95% confidence intervals. Data were analyzed using Mann Whitney U test. (HIV-, n=20; HIV+ ART-, n=17).
the alveoli. We found that the proportions and numbers of CD8+ 
T cells (median, 68% vs. 32%, p<0.0001 and median 7 × 106 vs. 
7 × 105/100ml of BAL fluid, p<0.0001, respectively) and B cells 
(median 1.8% vs. 0.8%, p=0.0014 and median 7 × 104 vs. 
1 × 104/100ml of BAL fluid, p<0.0001, respectively) in 
BAL fluid were higher in HIV-infected adults compared to 
HIV-uninfected controls (Figure 2C–2F). The proportion and 
numbers of γδ T cells were also higher in BAL fluid from HIV-
infected adults compared HIV-uninfected controls (median 1.4% 
vs. 0.8%, p=0.036 and median 1 × 105 vs. 2 × 104/100ml of 
BAL fluid, p=0.0002, respectively) (Figure 3A and 3B).
In contrast, the proportions of CD4+ T cells and NK cells in 
BAL fluid were lower in HIV-infected adults compared to 
HIV-uninfected controls (CD4+ T cell, median 2% vs. 4%, 
p<0.0001; NK cells, median 1% vs. 2%, p<0.0001) (Figure 2C 
and Figure 3C). However, the numbers showed no difference in 
CD4+ T cells (median 1.1 × 106 vs. 1.0 × 106/100 ml of BAL fluid, 
p=0.7065) and NK cells (median 5.4 × 104 vs. 4.9 × 104/100ml 
of BAL fluid, p=0.8911) between HIV-infected adults and 
HIV-uninfected controls (Figure 2D and Figure 3D). Further-
more, there is no statistically significant difference between the 
alveolar CD4 T cell count in individuals with peripheral blood 
CD4 count of less than 350 compared to those with a peripheral 
blood CD4 count of greater than 350 (Median [Interquartile range] 
1.9 × 106 [0.9-2.2 ×106] vs. 0.9 × 106[0.4-2.2 × 106]/100ml of BAL 
fluid, p=0.1905). These findings demonstrate that HIV infection 
has a differential impact on alveolar lymphocyte populations.
Differential impact of HIV infection on lymphocyte subsets 
in the alveolar and blood compartments
We then investigated the similarities and differences of HIV- 
associated changes in cell composition between BAL fluid and 
peripheral blood. In agreement with BAL fluid, the proportions 
of CD8+  T cells in peripheral blood were higher in HIV infected 
adults compared to HIV-uninfected controls (Median 47% vs. 24%, 
p<0.0001) (Supplementary Figure 1). The proportions of CD4+ 
T cells in peripheral blood were lower in HIV-infected adults 
compared to HIV-uninfected controls (Median 20% vs. 46%, 
p<0.0001) (Supplementary Figure 1). In contrast with BAL fluid, 
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the proportion of B cells in peripheral blood was lower in HIV-
infected adults compared to HIV-uninfected controls (Median 
5.8% vs. 9.4%, p=0.0472) (Supplementary Figure 1). The propor-
tion of CD3+CD56+ NK T cells in peripheral blood was lower in 
HIV-infected adults compared to HIV-uninfected controls (Median 
0.03% vs. 0.09%, p=0.0386) (Supplementary Figure 1). The 
proportion of CD8 γδ T cells in peripheral blood was higher in 
HIV-infected adults compared to HIV-uninfected controls (Median 
1.9% vs. 0.76%, p=0.0229) (Supplementary Figure 1). The findings 
show that HIV infection differentially impacts lymphocyte popula-
tions in the alveolar space and peripheral blood compartments.
Differential impact of HIV infection on monocyte subsets in 
the alveolar and blood compartments
Next, we investigated the impact of HIV infection on the 
monocyte population in BAL fluid compared to peripheral blood. 
The gating strategy is illustrated in Figure 4. First we determined 
the composition of the monocyte cell population in BAL fluid 
in comparison to peripheral blood. We found that irrespective 
of HIV status CD14+ CD16+ intermediate monocytes were the 
predominant subset in BAL fluid, followed by CD14++CD16lo 
classical monocytes and then CD14loCD16+ non-classical mono-
cytes (HIV-, Median 63% vs. 33% vs. 5%; HIV+, Median 81% 
vs. 13% vs. 9%) (Figure 5A and 5C). In blood, irrespective of 
HIV status, CD14++ CD16lo classical monocytes were the predomi-
nant monocyte subset, followed by CD14loCD16+ non-classical 
monocytes and then CD14+CD16+ intermediate monocytes (HIV-, 
median 74% vs. 18% vs. 9%; HIV+, median 73% vs. 23% vs. 8%) 
(Figure 5B and 5D).
Second, we compared the proportions and numbers of mono-
cyte population in BAL fluid and peripheral blood between HIV-
infected adults and HIV-uninfected controls. In BAL fluid, we 
found that the proportion and numbers of CD14+CD16lo classical 
monocytes were lower in HIV-infected adults compared to 
HIV-uninfected controls (median 13% vs. 33%, p=0.0002 and 
median 1 × 105 vs. 2.8 × 105 cells/100ml of BAL fluid, p=0.0001, 
respectively) (Figure 5C and 5E). In contrast, the proportion 
of CD14+CD16+ intermediate monocytes was higher in HIV-
infected adults compared the HIV-uninfected controls (median, 
Figure 4. Representative flow cytometry plots for characterising myeloid cells in BAL fluid from an HIV-uninfected adult. BAL cells 
were stained with fluorochrome-conjugated antibodies.
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Figure 5. Proportions and numbers of monocyte subsets in BAL fluid and peripheral blood from ART-naïve HIV-infected compared to 
HIV-uninfected individuals. BAL cells and PBMCs were stained with fluorochrome-conjugated antibodies. A) Flow cytometry representative 
plot of stained BAL sample from an HIV-uninfected control. B) Flow cytometry representative plot of stained peripheral blood sample 
from an HIV-uninfected control. C) Proportion of monocytes subsets in BAL fluid. D) Proportion of monocyte subsets in peripheral blood. 
E) Numbers of monocytes subsets in BAL fluid. F) Numbers of monocyte subsets in peripheral blood.The horizontal bars represent median 
and 95% confidence intervals. Data were analyzed using Mann Whitney U test. (BAL fluid, HIV-, n = 20; HIV+ ART-, n = 17; PBMC, HIV-, n=16; 
HIV+ ART-, n=14).
80% vs. 64%, p=0.0011) but the numbers were similar between 
the two groups (median 6.0 × 105 vs. 7.7 × 105 cells/100ml 
of BAL fluid, p=0.8628) (Figure 5C and 5E). In blood, we 
found that the numbers of CD14+ CD16lo classical monocytes 
(median 110 vs.  60 cells/1000 mm3, p=0.0237), CD14+CD16+ 
intermediate monocyets (median 20 vs. 6 cells/1000 mm3, 
p=0.0362) and CD14loCD16+ non classical monocytes (median 
30 vs. 10 cells/1000 mm3, p=0.0316) were higher in HIV-infected 
adults compared to HIV-uninfected controls (Figure 5F). These 
findings underscore differences in the composition and the impact 
of HIV infection on immune cells in the lung and systemic 
compartments.
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Altered proportions of alveolar macrophages and dendritic 
cell populations in HIV-infected adults
Lastly, we investigated the impact of HIV on alveolar 
macrophages (AM), neutrophils and dendritic cell populations in 
BAL fluid. We found that the proportions of alveolar macrophages 
and myeloid dendritic cells were lower in HIV infected adults 
compared to HIV-uninfected controls (AM, median 73% vs. 80%, 
p=0.0109; mDC, median 0.6% vs. 0.9%, p=0.0036) (Figure 6A 
and 6C). The proportion of neutrophils and plasmacytoid 
dendritic cells was similar between HIV-infected adults and 
HIV-uninfected controls (neutrophils, median 0.34% vs. 0.14%, 
p=0.0789; pDC, median 0.04% vs. 0.05%, p=0.1947) (Figure 6A 
and 6C). The numbers of alveolar macrophages (median 
2.0 × 106 vs. 2.2 × 106 cells/100ml of BAL fluid, p=0.8628), 
neutrophils (median 6.2 × 104 vs. 8.4 × 104 cells/100ml 
of BAL) and dendritic cells (mDC, median 2.1 × 105 vs. 
2.7 × 105 cells/100ml of BAL fluid, p=0.2676; pDC, median 
1.3 × 105  vs. 1.7 × 105 cells/100ml of BAL fluid, p=0.5328) were 
Figure 6. Proportions and numbers of alveolar macrophages, neutrophils and dendritic cells in BAL fluid from ART-naïve HIV-infected 
compared  to  HIV-uninfected  individuals. BAL cells were stained with fluorochrome-conjugated antibodies. A) Proportion of alveoalar 
macrophages and neutrophils in BAL fluid. B) Numbers of alveoalar macrophages and neutrophils in BAL fluid. C) Proportion of dendritic cell 
subsets in BAL fluid. D) Numbers of dendritic cell subsets in BAL fluid. The horizontal bars represent median and 95% confidence intervals. 
Data were analyzed using Mann Whitney U test. (HIV-, n = 20; HIV+ ART-, n = 17).
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similar between the HIV-infected adults and HIV-uninfected 
controls (Figure 6B and 6D). Taken together, the findings show 
that chronic HIV-infection is associated with a disruption in the 
homeostatic proportions of alveolar macrophage and dendritic 
cell populations.
Discussion
We report the broad impact of HIV infection on immune cell 
populations in the alveolar space beyond the well-characterised 
CD8+T cell alveolitis observed in previous studies5,6,9,10. We show 
that in addition to CD8+ T cells, B cells and γδ T cells are increased, 
while classical monocytes are decreased in BAL fluid from 
ART-naïve HIV-infected adults compared to HIV-uninfected 
individuals. We further show generalised disruption in the pro-
portions of immune cell subsets including alveolar macrophages, 
CD4+ T cells, myeloid dendritic cells, intermediate monocytes 
and NK cells in BAL fluid of asymptomatic chronic HIV-infected 
adults.
Although HIV-infection was associated with accumulation of 
B cells and γδ T cells in BAL fluid, their contribution to pulmonary 
immunity during chronic HIV infection is incompletely understood. 
However, previous studies have reported HIV-associated impair-
ment of function of these two cell subsets in peripheral blood19–21. 
Consistent with what has been observed in the systemic circulation, 
hyperglobulinemia has been reported in BAL fluid of HIV-infected 
adults22,23, but the antibodies have impaired opsonic function24. It 
is plausible that the HIV-associated increase in B cells in the lung 
results in increased antibody production and BAL fluid hyperglob-
ulinemia. Furthermore, the increase in γδ T cells that we found in 
the present study supports the findings of Agostini et. al.25, who 
showed that HIV-infected individuals with CD8+ T cell alveolitis 
had increased γδ T cells in BAL fluid, which were predominantly 
of the Vδ2 subset. However, HIV infection was also associated 
with anergic γδ T cells that were characterised by their 
substantially deficient response to phosphoantigens26–28. Taken 
together, the findings of previous studies lead us to postulate 
that despite the increase in numbers, lung B cells and γδ T cells 
from HIV-infected individuals have impaired function as their 
blood counterparts.
HIV infection is associated with massive depletion of mucosal 
CD4+ T cells in the gut29,30 and gradual decline in peripheral 
blood CD4+ T cells15. We have shown preserved mucosal 
CD4+ T cells in BAL fluid from chronic HIV-infected adults, 
even in those with depleted peripheral blood CD4+ T cells. Our 
findings are consistent with previous work that showed lung 
CCR5+CD4+ T cells are not massively depleted during HIV 
infection31. However, it is not clearl whether these preserved 
mucosal CD4+ T cells in BAL fluid would also be true in indi-
viduals with symptomatic chronic HIV infection. The mechanisms 
behind this preservation of alveolar CD4+ T cells is unclear and 
warrants further investigation. However, Mahlknecht et. al. has 
shown that macrophages can prevent CD4+ T cell apoptosis 
in vitro via cell to cell contact using a mechanism that involves 
stimulation of nef-expressing CD4+ T cells with macrophage mem-
brane-bound TNF32. Nef in presence of TNF stimulation pro-
motes activation of anti-apoptotic transcription factor NF-κB, 
resulting in blockade of caspase-8 activation and subsequent 
apoptosis32. It is therefore plausible that alveoalar macrophages 
could promote survival of CD4+ T cells in the lung through 
similar mechanisms, but this warrants further investigation. 
However, although alveolar CD4+ T cells are not massively 
depleted during chronic HIV infection, their functional capacity 
is perturbed5–7.
Consistent with others33–35, we have showed that CD16+CD14+ 
intermediate monocytes were the predominant subset in 
BAL fluid. The lower proportion of CD14+CD16lo classical 
monocytes in BAL compared to peripheral blood is consist-
ent with work from Baharom et al., which comprehensively 
characterized monocyte subsets and their function in the lung 
mucosa36. CD16+ monocytes and AM have been shown to 
be permissive to HIV infection8,37. The abundance of inter-
mediate monocytes and AM in BAL fluid increases potential 
cellular targets for HIV. Our findings that AM are preserved 
during chronic HIV infection, may partly be attributed to the 
long life span of these cells38,39, as well as their resistance to 
the cytopathic effects of HIV40,41. In contrast, we observed 
a depletion in classical monocytes in BAL fluid from HIV- 
infected individuals. The mechanism for the selective depletion 
of classical monocytes is unclear, but might involve HIV-induced 
apoptosis42 or loss/downregulation of surface CD1443. In steady 
state, alveolar macrophages originate from erythro-myeloid 
progenitors (EMPs), while monocytes originate from haemat-
opoietic stem cells (HSCs)44, hence the differential impact of 
HIV on these subsets might be due to the distinct nature of their 
source of origin. On the other hand, during an inflam-
matory state, classical monocytes are thought to differ-
entiate into lung macrophages and contribute to clear-
ance of invading pathogens45. Presence of a wide array of 
HIV-permissive cells in the lung, including recruited and resident 
cells, could contribute to maintenance of local viral production 
and subsequent disruption of immune cell populations and 
homeostasis in this compartment.
A potential limitation of the study is that the numbers of BAL 
cell subsets are extremely difficult to measure with a very high 
degree of accuracy due to the variations in the dilution factor of 
epithelial lining fluid and differences in BAL fluid volume return. 
However, using a method utilised in previous studies5,6, we 
calculated numbers of cell subsets using the BAL cell count 
obtained from a haemocytometer combined with proportions 
obtained by immunophenotyping. We have confidence in the 
reliability of this method to measure the numbers for the other cell 
subsets, as we have replicated the observation that the absolute 
number of CD8+ T cells is higher in HIV-infected adults 
compared with HIV-uninfected individuals5,6,9,10. Furthermore, 
using data from our previous work that focused on measur-
ing cytokines in BAL fluid, we found no statistically significant 
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difference in concentration of urea in BAL fluid between 
HIV-infected adults compared to HIV-uninfected individuals, 
suggesting that permeability of the alveolar space might not be 
different in the two groups (unpublished). 
In conclusion, our findings show that HIV infection is associated 
with broad alteration of immune cell populations in the lung. 
Disruption in immune homeostasis has been shown to lead to 
increased susceptibility to both infectious and non-infectious 
diseases. The broad alteration of immune cell populations 
in the lung in part explain the propensity to LRTI in HIV-infected 
individuals. However, the degree to which successful anti- 
retroviral therapy restores the composition of immune cells in the 
lung warrants further investigation.
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